We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 May 21
The transaction will enable Roivant Sciences to become a public entity and is expected to be listed on…
28 Apr 21
Exscientia intends to use the funding to advance its pipeline through clinical testing along with expanding its technology…
04 Mar 21
Exscientia intends to use proceeds from the financing round to further advance AI drug discovery platform and portfolio
11 Feb 21
The collaboration will focus on a specific neuroinflammatory pathway associated with the development of AD
11 Dec 20
The acquisition will help expand Boehringer Ingelheim’s focus on patients with difficult-to-treat solid tumours
10 Dec 20
Exscientia intends to use its AI-based Centaur platforms for genome scale AI-drug discovery and address critical global health…
08 Dec 20
Pfizer will leverage its extensive data and expertise, while PostEra its technology capabilities to advance the preclinical drug…
27 Nov 20
CX-5461 works to stabilise DNA G-quadruplexes of cancer cells and facilitates disruption of the replication fork in cancer…
27 Oct 20
Bayer will add AskBio’s advanced adeno-associated virus (AAV)-based gene therapy platform to its cell and gene therapy (CGT)…
03 Sep 20
Janssen’s decision is based on results from the interim analyses of the Phase 3 clinical study of Pimodivir…